Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-02-Speech-3-293-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110202.19.3-293-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Although a certain amount of progress has been made, tuberculosis continues to be one of the main causes of mortality worldwide, especially in developing countries, accounting for nearly 2 million deaths a year. The situation in Romania is also worth mentioning, where 110 cases per 100 000 inhabitants are recorded, against a European average of 39 cases per 100 000.
Access to health is a universal right and it is not the financial costs of it which should concern us. An imbalance persists between the industrialised and developing countries. We must show solidarity and support using every method available the ‘Stop Tuberculosis’ programme launched by the World Health Organisation (WHO).
It is Europe’s duty to look for viable, innovative methods to guarantee the funding for research in order to combat tuberculosis and other transmissible diseases. The Tuberculosis Vaccine Initiative (TBVI), an organisation supported by the European Union, offers a solution to the current situation by creating accessible vaccines at affordable prices, which can be supplied to the population through a structured vaccination programme. The inclusion of the TBVI in the EU 2020 strategy may be the solution enabling Europe to strengthen its strategic independence in the battle against tuberculosis and its position as a leading innovator."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples